Smoking, Radiation Therapy, and Contralateral Breast Cancer Risk in Young Women
Menée à partir de données portant sur 2 212 témoins et 1 521 patientes atteintes d'un cancer invasif du sein diagnostiqué entre 1985 et 2008 avant l'age de 55 ans, cette étude analyse l'association entre le tabagisme, la radiothérapie et le risque de cancer du sein controlatéral
Evidence is mounting that cigarette smoking contributes to second primary contralateral breast cancer (CBC) risk. Whether radiation therapy (RT) interacts with smoking to modify this risk is unknown. In this multicenter, individually-matched case-control study, we examined the association between RT, smoking, and CBC risk. The study included 1,521 CBC cases and 2,212 controls with unilateral breast cancer, all diagnosed with first invasive breast cancer between 1985–2008 at age <55 years. Absorbed radiation doses to contralateral breast regions were estimated with thermoluminescent dosimeters in tissue-equivalent anthropomorphic phantoms and smoking history was collected by interview. Rate ratios (RRs) and 95% confidence intervals (CIs) for CBC risk were estimated by multivariable conditional logistic regression. There was no interaction between any measure of smoking with RT to increase CBC risk (eg, the interaction of continuous RT dose with smoking at first breast cancer diagnosis [ever/never]: RR = 1.00, 95% CI = 0.89–1.14; continuous RT dose with years smoked: RR = 1.00, 95% CI = 0.99–1.01; and continuous RT dose with lifetime pack-years: RR = 1.00, 95% CI = 0.99–1.01). There was no evidence that RT further increased CBC risk in young women with first primary breast cancer who were current smokers or had smoking history.